New diabetes clinical trial: Dapagliflozin Therapy In Cardiac Surgery

Published on: November 18, 2022 at 11:00AM
Conditions:   Diabetes Mellitus, Type 2;   Cardiac Surgery
Intervention:   Drug: Dapagliflozin
Sponsor:   China National Center for Cardiovascular Diseases
Recruiting
https://ift.tt/hyL1iB0